StreetAccount Summary: EU stocks reaching new 52-week highs/lows (127 total)
FDA grants 510(k) clearance for Grifols' Erytra Eflexis (€9.94, 0.00)
Grifols successfully completes Biotest delisting (€10.47, 0.00)
Powered by FactSet Research Systems Inc.